| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.038 | 0.9 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.9 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |